目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Application
1.1.3. End-use
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. End-use outlook
2.2.4. Regional outlook
2.3. Competitive Insights

Chapter 3. Preclinical Imaging Market Variables, Trends & cope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Technological advancements
3.4.1.2. Growing number of investments and funding in research and development
3.4.2. Market restraint analysis
3.4.2.1. Strict regulatory framework
3.5. Preclinical Imaging Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies

Chapter 4. Preclinical Imaging Market: Product Estimates &Trend Analysis
4.1. Definitions and Scope
4.1.1. CT Imaging
4.1.2. MRI Imaging
4.1.3. PET/SPECT Imaging
4.1.4. Multi-modal Imaging
4.1.5. Optical Imaging
4.1.6. Ultrasound Imaging
4.1.7. Photoacoustic Imaging
4.1.8. Reagents
4.1.9. Services
4.2. Product Market Share, 2018 & 2030
4.3. Segment Dashboard
4.4. Preclinical Imaging Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. CT imaging
4.5.1.1. CT imaging market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. MRI imaging
4.5.2.1. MRI imaging market estimates and forecast 2018 to 2030 (USD Million)
4.5.3. PET/SPECT imaging
4.5.3.1. PET/SPECT imaging market estimates and forecast 2018 to 2030 (USD Million)
4.5.4. Multi-modal imaging
4.5.4.1. Multi-modal imaging market estimates and forecast 2018 to 2030 (USD Million)
4.5.5. Optical imaging
4.5.5.1. Optical imaging market estimates and forecast 2018 to 2030 (USD Million)
4.5.6. Ultrasound imaging
4.5.6.1. Ultrasound imaging market estimates and forecast 2018 to 2030 (USD Million)
4.5.7. Photoacoustic imaging
4.5.7.1. Photoacoustic imaging market estimates and forecast 2018 to 2030 (USD Million)
4.5.8. Reagents
4.5.8.1. Reagents imaging market estimates and forecast 2018 to 2030 (USD Million)
4.5.9. Services
4.5.9.1. Services market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Preclinical Imaging Market: Application Estimates ∓ Trend Analysis
5.1. Definitions and Scope
5.1.1. Research and Development
5.1.2. Drug Discovery
5.2. Application Market Share, 2018 & 2030
5.3. Segment Dashboard
5.4. Preclinical Imaging Market by Application Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Research and Development
5.5.1.1. Research and development market estimates and forecast 2018 to 2030 (USD Million)
5.5.2. Drug Discovery
5.5.2.1. Drug discovery market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Preclinical Imaging Market: End-use Estimates &Trend Analysis
6.1. Definitions and Scope
6.1.1. Pharma and Biotech Companies
6.1.2. Research Institutes
6.1.3. Others
6.2. End-use Market Share, 2018 & 2030
6.3. Segment Dashboard
6.4. Preclinical Imaging Market by End-use Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. Pharma and Biotech Companies
6.5.1.1. Pharma and biotech companies market estimates and forecast 2018 to 2030 (USD Million)
6.5.2. Research Institutes
6.5.2.1. Research institutes market estimates and forecast 2018 to 2030 (USD Million)
6.5.3. Others
6.5.3.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Preclinical Imaging Market: Regional Estimates & Trend Analysis
7.1. Regional market share analysis, 2020 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2020
7.4.1. North America
7.4.2. Europe
7.4.3. Asia Pacific
7.4.4. Latin America
7.4.5. Middle East and Africa
7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East and Africa
7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030:
7.7. North America
7.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.7.2. U.S.
7.7.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.7.3. Canada
7.7.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.8. Europe
7.8.1. UK
7.8.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.8.2. Germany
7.8.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.8.3. France
7.8.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.8.4. Italy
7.8.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.8.5. Spain
7.8.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.8.6. Sweden
7.8.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.8.7. Norway
7.8.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.8.8. Denmark
7.8.8.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.9. Asia Pacific
7.9.1. Japan
7.9.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.9.2. China
7.9.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.9.3. India
7.9.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.9.4. South Korea
7.9.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.9.5. Australia
7.9.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.9.6. Thailand
7.9.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.9.6.2.
7.10. Latin America
7.10.1. Brazil
7.10.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.10.2. Mexico
7.10.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.10.3. Argentina
7.10.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.11. MEA
7.11.1. Saudi Arabia
7.11.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.11.2. South Africa
7.11.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.11.3. UAE
7.11.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.11.4. Kuwait
7.11.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2022
8.3.4. Bruker Corporation
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Siemens Healthineers AG
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. GE Healthcare
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. TriFoil Imaging
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. PerkinElmer, Inc.
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. VisualSonic Inc. (Fujifilm)
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Mediso Ltd.
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Agilent Technologies
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. MR Solutions
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
8.3.13. MILabs B.V.
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Product benchmarking
8.3.13.4. Strategic initiatives
8.3.14. Molecubes
8.3.14.1. Company overview
8.3.14.2. Financial performance
8.3.14.3. Product benchmarking
8.3.14.4. Strategic initiatives

List of Tables
Table 1 List of Abbreviations
Table 2 North America preclinical imaging market, by region, 2018 - 2030 (USD Million)
Table 3 North America preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 4 North America preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 5 North America preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 6 U.S. preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 7 U.S. preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 8 U.S. preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 9 Canada preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 10 Canada preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 11 Canada preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 12 Europe preclinical imaging market, by region, 2018 - 2030 (USD Million)
Table 13 Europe preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 14 Europe preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 15 Europe preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 16 Germany preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 17 Germany preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 18 Germany preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 19 UK preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 20 UK preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 21 UK preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 22 France preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 23 France preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 24 France preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 25 Italy preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 26 Italy preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 27 Italy preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 28 Spain preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 29 Spain preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 30 Spain preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 31 Sweden preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 32 Sweden preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 33 Sweden preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 34 Denmark preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 35 Denmark preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 36 Denmark preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 37 Norway preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 38 Norway preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 39 Norway preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 40 Asia Pacific preclinical imaging market, by region, 2018 - 2030 (USD Million)
Table 41 Asia Pacific preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 42 Asia Pacific preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 43 Asia Pacific preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 44 China preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 45 China preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 46 China preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 47 Japan preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 48 Japan preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 49 Japan preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 50 India preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 51 India preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 52 India preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 53 Australia preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 54 Australia preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 55 Australia preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 56 South Korea preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 57 South Korea preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 58 South Korea preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 59 Thailand preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 60 Thailand preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 61 Thailand preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 62 Latin America preclinical imaging market, by region, 2018 - 2030 (USD Million)
Table 63 Latin America preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 64 Latin America preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 65 Latin America preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 66 Brazil preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 67 Brazil preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 68 Brazil preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 69 Mexico preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 70 Mexico preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 71 Mexico preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 72 Argentina preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 73 Argentina preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 74 Argentina preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 75 Middle East and Africa preclinical imaging market, by region, 2018 - 2030 (USD Million)
Table 76 Middle East and Africa preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 77 Middle East and Africa preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 78 Middle East and Africa preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 79 South Africa preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 80 South Africa preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 81 South Africa preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 85 UAE preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 86 UAE preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 87 UAE preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 88 Kuwait preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 89 Kuwait preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 90 Kuwait preclinical imaging market, by end-use, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Preclinical imaging market: market outlook
Fig. 14 Preclinical imaging market competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Preclinical imaging market driver impact
Fig. 20 Preclinical imaging market restraint impact
Fig. 21 Preclinical imaging market strategic initiatives analysis
Fig. 22 Preclinical imaging market: product movement analysis
Fig. 23 Preclinical imaging market: product outlook and key takeaways
Fig. 24 CT market estimates and forecast, 2018 - 2030
Fig. 25 MRI market estimates and forecast, 2018 - 2030
Fig. 26 PET/SPECT market estimates and forecast, 2018 - 2030
Fig. 27 Multi-Modal market estimates and forecast, 2018 - 2030
Fig. 28 Optical market estimates and forecast, 2018 - 2030
Fig. 29 Ultrasound market estimates and forecast, 2018 - 2030
Fig. 30 Photoacoustic market estimates and forecast, 2018 - 2030
Fig. 31 Reagents market estimates and forecast, 2018 - 2030
Fig. 32 Services market estimates and forecast, 2018 - 2030
Fig. 33 Preclinical imaging market: application movement analysis
Fig. 34 Preclinical imaging market: application outlook and key takeaways
Fig. 35 Research and development market estimates and forecast, 2018 - 2030
Fig. 36 Drug discovery market estimates and forecast, 2018 - 2030
Fig. 37 Preclinical imaging market: end-use movement analysis
Fig. 38 Preclinical imaging market: end-use outlook and key takeaways
Fig. 39 Pharma and biotech companies market estimates and forecast, 2018 - 2030
Fig. 40 Research institutes market estimates and forecast, 2018 - 2030
Fig. 41 Others market estimates and forecast, 2018 - 2030
Fig. 42 Global preclinical imaging market: regional movement analysis
Fig. 43 Global preclinical imaging market: regional outlook and key takeaways
Fig. 44 Global market shares and leading players
Fig. 45 North America market share and leading players
Fig. 46 Europe market share and leading players
Fig. 47 Asia Pacific market share and leading players
Fig. 48 Latin America market share and leading players
Fig. 49 Middle East & Africa market share and leading players
Fig. 50 North America: SWOT
Fig. 51 Europe SWOT
Fig. 52 Asia Pacific SWOT
Fig. 53 Latin America SWOT
Fig. 54 MEA SWOT
Fig. 55 North America, by country
Fig. 56 North America
Fig. 57 North America market estimates and forecast, 2018 - 2030
Fig. 58 U.S.
Fig. 59 U.S. market estimates and forecast, 2018 - 2030
Fig. 60 Canada
Fig. 61 Canada market estimates and forecast, 2018 - 2030
Fig. 62 Europe
Fig. 63 Europe. market estimates and forecast, 2018 - 2030
Fig. 64 UK
Fig. 65 UK market estimates and forecast, 2018 - 2030
Fig. 66 Germany
Fig. 67 Germany market estimates and forecast, 2018 - 2030
Fig. 68 France
Fig. 69 France market estimates and forecast, 2018 - 2030
Fig. 70 Italy
Fig. 71 Italy market estimates and forecast, 2018 - 2030
Fig. 72 Spain
Fig. 73 Spain market estimates and forecast, 2018 - 2030
Fig. 74 Sweden
Fig. 75 Sweden market estimates and forecast, 2018 - 2030
Fig. 76 Denmark
Fig. 77 Denmark market estimates and forecast, 2018 - 2030
Fig. 78 Norway
Fig. 79 Norway market estimates and forecast, 2018 - 2030
Fig. 80 Asia Pacific
Fig. 81 Asia Pacific market estimates and forecast, 2018 - 2030
Fig. 82 China
Fig. 83 China market estimates and forecast, 2018 - 2030
Fig. 84 Japan
Fig. 85 Japan market estimates and forecast, 2018 - 2030
Fig. 86 India
Fig. 87 India market estimates and forecast, 2018 - 2030
Fig. 88 Australia
Fig. 89 Australia market estimates and forecast, 2018 - 2030
Fig. 90 South Korea
Fig. 91 South Korea market estimates and forecast, 2018 - 2030
Fig. 92 Thailand
Fig. 93 Thailand market estimates and forecast, 2018 - 2030
Fig. 94 Latin America
Fig. 95 Latin America market estimates and forecast, 2018 - 2030
Fig. 96 Brazil
Fig. 97 Brazil market estimates and forecast, 2018 - 2030
Fig. 98 Mexico
Fig. 99 Mexico market estimates and forecast, 2018 - 2030
Fig. 100 Argentina
Fig. 101 Argentina market estimates and forecast, 2018 - 2030
Fig. 102 Middle East and Africa
Fig. 103 Middle East and Africa. market estimates and forecast, 2018 - 2030
Fig. 104 Saudi Arabia
Fig. 105 Saudi Arabia market estimates and forecast, 2018 - 2030
Fig. 106 South Africa
Fig. 107 South Africa market estimates and forecast, 2018 - 2030
Fig. 108 UAE
Fig. 109 UAE market estimates and forecast, 2018 - 2030
Fig. 110 Kuwait
Fig. 111 Kuwait market estimates and forecast, 2018 - 2030
Fig. 112 Participant categorization- preclinical imaging market
Fig. 113 Market share of key market players- preclinical imaging market